Across TCGA pan-cancer cohorts, UBAP1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated UBAP1 data layer compared with 20 for mass-spec protein and 1 for mutation status.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher UBAP1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated UBAP1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and PDAC show a favorable association.
HNSC, PDAC, and UCEC are the cancer types where UBAP1 mass-spec protein most reproducibly stratifies survival.